-
Doxorubicin Market Size Worth $1.86 Billion by 2029 - Exclusive Report by The Business Research Company
24 Nov 2025 09:30 GMT
… Ltd.
• Cipla Limited
• Hikma Pharmaceuticals
• Mylan Pharmaceuticals Inc.
• Accord Healthcare Ltd.
• TTY …
-
Federal Circuit Affirms Presumption of Separateness in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al., C.A. No. 24-2351 (Fed. Cir. Mar. 14, 2025)
11 Apr 2025 23:15 GMT
… in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al. and up …
-
Pfizer board approves marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacitane in India
21 Feb 2025 09:04 GMT
… Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited. The agreement focuses … Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited (“Mylan”) for Marketing …
-
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025)
19 Feb 2025 02:31 GMT
… Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir 2025) … Court.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025) … Taranto
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2025 …
-
Latest Federal Court Cases: Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
05 Feb 2025 02:06 GMT
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., Appeal Nos. 2024-1965, - …
-
Former First Responder who was Area Captain in Fire Department, James Lee Bolyard, Passes at Age 60
10 Nov 2025 06:51 GMT
… then took a job at Mylan Pharmaceuticals where he worked until it …
-
WVSSAC releases official high school football playoff schedule
09 Nov 2025 17:55 GMT
… at 7 p.m. at Mylan Pharmaceuticals Stadium
#9 Musselman (4-6 …
-
Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch
12 Jan 2024 18:15 GMT
… Announcement
PITTSBURGH – Jan. 18, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is …
-
Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch
27 Oct 2023 15:09 GMT
… on some vials
Company Name:
Mylan Pharmaceuticals, Inc. a Viatris Company
Brand … - PITTSBURGH – April 12, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is …
-
Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)
14 Sep 2023 04:14 GMT
… Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc.
The case arose in … inter partes review initiated by Mylan Pharmaceuticals over Reissue Patent No. RE47 … ).
Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)
Panel …
About
© 1995-2025